Clinical trial
Gastrointestinal Assessment of Three Novel Resistant Starch Type IV
NCT03255603 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gastrointestinal Assessment of Three Novel Resistant Starch Type IV
- Lead sponsor
- University of Alberta
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2017
- Completion date
- December 22, 2018
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diet modification